Steroid-Refractory Autoimmune Myocarditis after Pembrolizumab Therapy: Failure of Equine Anti-Thymocyte Globulin to Prevent Heart Failure
Abstract
While immune checkpoint inhibitors (ICIs) are improving outcomes for many cancers, they can have severe adverse effects. Though cardiac immune-related adverse effects (irAEs) are rare,
Article Information
| Journal | SF Journal of Clinical Case Reports |
| Article Type | Case Report |
| Volume | 2 |
| Issue | 1 |